- Home
- KIO vs ABSI Comparison
KIO vs ABSI Comparison
Compare KIO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIO
- ABSI
- Stock Information
- Founded
- KIO 2011
- ABSI 2011
- Country
- KIO United States
- ABSI United States
- Employees
- KIO 2400
- ABSI N/A
- Industry
- KIO Investment Managers
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- KIO Finance
- ABSI Health Care
- Exchange
- KIO Nasdaq
- ABSI Nasdaq
- Market Cap
- KIO 404.1M
- ABSI 457.6M
- IPO Year
- KIO N/A
- ABSI 2021
- Fundamental
- Price
- KIO $13.02
- ABSI $2.99
- Analyst Decision
- KIO
- ABSI Strong Buy
- Analyst Count
- KIO 0
- ABSI 6
- Target Price
- KIO N/A
- ABSI $8.67
- AVG Volume (30 Days)
- KIO 136.5K
- ABSI 2.5M
- Earning Date
- KIO 01-01-0001
- ABSI 11-12-2024
- Dividend Yield
- KIO 10.82%
- ABSI N/A
- EPS Growth
- KIO N/A
- ABSI N/A
- EPS
- KIO N/A
- ABSI N/A
- Revenue
- KIO N/A
- ABSI $4,207,000.00
- Revenue This Year
- KIO N/A
- ABSI $7.12
- Revenue Next Year
- KIO N/A
- ABSI $202.16
- P/E Ratio
- KIO N/A
- ABSI N/A
- Revenue Growth
- KIO N/A
- ABSI N/A
- 52 Week Low
- KIO $10.52
- ABSI $2.45
- 52 Week High
- KIO $13.59
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- KIO 28.54
- ABSI 43.82
- Support Level
- KIO $13.56
- ABSI $2.79
- Resistance Level
- KIO $13.78
- ABSI $4.11
- Average True Range (ATR)
- KIO 0.14
- ABSI 0.43
- MACD
- KIO -0.04
- ABSI -0.02
- Stochastic Oscillator
- KIO 15.54
- ABSI 11.15
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.